DEA to hold hearing on rescheduling marijuana to Schedule III on December 2, focusing on logistics, not testimonies.
The U.S. Drug Enforcement Administration (DEA) on Tuesday said that a preliminary hearing on the Department of Justice’s ...
Now a lawsuit says DEA acting in bad faith over marijuana. David Heldreth, CEO of psychedelic research firm Panacea Plant ...
A DEA administrative law judge has denied MedPharm's motion to participate in the December 2 marijuana rescheduling ...
As the federal government considers loosening restrictions on marijuana, the Drug Enforcement Administration is scheduled to convene a court hearing to flesh out the Biden administration’s ...
The motion, which asks the DOJ to take over moving cannabis down the list, argues the DEA has "stacked the deck" against ...
DEA and anti-cannabis group must respond to allegations of unlawful talks by November 25. Legal tensions rise ahead of ...